According to Emergen Research, the global biobanking market size was USD 29.79 billion in 2020 and is expected to reach USD 67.90 billion in 2030 and register a revenue CAGR of 8.6% during the forecast period.
Emergen Research has published its latest report titled “Biobanking Market Size, Share, Trends, By Product & Services (Equipment, Consumables, Services, Software), By Sample Type (Biological Fluids, Human Tissues, Blood Products, Nucleic Acids, Human Waste Products, Cell Lines), By Storage Type (Automated, Manual), By Application, and By Region Forecast to 2030”
According to Emergen Research, the global biobanking market size was USD 29.79 billion in 2020 and is expected to reach USD 67.90 billion in 2030 and register a revenue CAGR of 8.6% during the forecast period.
Market Dynamics:
A biobank is a type of biorepository used for storing biological samples such as blood, urine, plasma, serum, tissues, and associated information for academic and research purposes. These biobanks are an important resource in medical research, supporting research related to genomics and precision medicine. One of the key factors contributing to rise in demand for biobanking services and facilities is the increasing prevalence of various chronic, life-threatening diseases such as cancer, neurological disorders, cardiovascular diseases, and hematological conditions across the globe. Revenue growth of the global market is significantly driven by factors such as increasing demand for personalized medicine, rising research activities for rare case diseases, and increasing investments in genomics and proteomics research. In addition, increasing product launches, high preference for automated machines, and increasing need for cost-effective drug discovery are expected to fuel market growth going ahead.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/926
However, high cost of automation, rising concerns about data privacy and ethical issues related to procurement of biospecimen samples, lack of counseling and training on medical ethics, and low awareness about biobanking especially in the developing countries are key factors expected to hamper overall market growth.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Human Tissues Segment to Register Steady Revenue Growth:
The human tissues segment is expected to register steady revenue growth over the forecast period owing to increasing prevalence of chronic and infectious diseases, increasing investments in cancer-based research activities, and availability of biobanks with advanced facilities and technologies for storing and retrieving human tissues.
Biobanking Equipment Segment to Account for Largest Revenue Share:
The biobanking equipment segment is expected to account for largest revenue share during the forecast period. Factors such as rising number of biobanks across the globe, availability of a wide range of equipment for sample collection, preparation, transport, and analysis, and increasing focus on developed advanced biobanking equipment are expected to drive revenue growth of the segment during the forecast period.
Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/926
Asia Pacific to Register Rapid Revenue Growth:
The biobanking market in Asia Pacific is expected to register a rapid revenue CAGR over the forecast period owing to increasing prevalence of chronic disorders and infectious diseases, improving healthcare infrastructure and research facilities, and rising funds by public and private organizations. In addition, increasing number of biobanks across the region, high requirement of blood and cell samples for research purposes, and high adoption of stem cell therapies for treating chronic conditions are expected to fuel Asia Pacific market growth going ahead. China, India, South Korea, and Japan are some key contributing countries in this region.
Major Companies in the Market Include:
- UK. Biobank Limited
- Medizinische Universität Graz
- Hamilton Company
- ASKION
- Azenta Life Sciences
- Qiagen
- Promega Corporation
- Integrated Biobank of Luxembourg (IBBL)
- Isenet Biobanking
- Thermo Fisher Scientific, Inc.
For the purpose of this report, Emergen Research has segmented the global biobanking market on the basis of product & services, sample type, storage type, application, and region:
Product & Services Outlook (Revenue, USD Billion; 2021–2030)
- Equipment
- Storage Equipment
- Sample Transport Equipment
- Sample Processing Equipment
- Sample Analysis Equipment
- Consumables
- Collection Consumables
- Storage Consumables
- Processing Consumables
- Analysis Consumables
- Services
- Supply Services
- Processing Services
- Storage Services
- Transport Services
- Software
Sample Type Outlook (Revenue, USD Billion; 2021–2030)
- Biological Fluids
- Human Tissues
- Blood Products
- Nucleic Acids
- Human Waste Products
- Cell Lines
Storage Type Outlook (Revenue, USD Billion; 2021–2030)
- Automated Storage
- Manual Storage
Application Outlook (Revenue, USD Billion; 2021–2030)
- Regenerative Medicine
- Life Science Research
- Clinical Research
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/biobanking-market
Regional Outlook (Revenue, USD Billion; 2021–2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Explore Similar Reports offered by Emergen Research:
The global nutrigenomics market size reached USD 389.4 Million in 2020 and is expected to register a CAGR of 16.2% during the forecast period. Market revenue growth is primarily driven by increasing global burden of nutrition-related noncommunicable diseases.
The global Sanger sequencing services market size was significantly robust in 2020 and is expected to register steady revenue CAGR over the forecast period. Increasing advancements in sequencing techniques, benefits of Sanger sequencing, and rising investments to accelerate R&D activities in genomics are key factors expected to drive market revenue growth over the forecast period. In addition, increasing application scope of Sangers sequencing technique has boosted deployment of this procedure and is another key factor expected to further contribute to revenue growth of the market going ahead.
The global whole exome sequencing (WES) market size was significantly robust in 2020 and is expected to register a steady revenue CAGR during the forecast period. Rapid adoption of cutting-edge technologies, and rising awareness regarding whole exome sequencing technology are some key factors expected to drive market revenue growth over the forecast period.
The global health data archiving market size is expected to reach USD 9.28 Billion in 2028 and register a revenue CAGR of 14.1% during the forecast period. Increasing volume of digital data and rapid deployment of cloud-based storage solutions are key factors driving global health data archiving market revenue growth.
The global gel documentation system market size reached USD 291.5 Million in 2020 and is expected to register a revenue CAGR of 3.6% during the forecast period. Major factors driving gel documentation system market revenue growth are rising prevalence of infectious diseases and genetic disorders, and rapid developments and advancements across pharmaceutical and biotechnological industries globally.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-biobanking-market